Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Akershus Universitetssykehus HF has 1 pending office action in Biotechnology & Pharmaceuticals. It involves 1 distinct examiner and a single distinct art unit, reflecting a highly focused prosecution path. This concentration suggests that the company's current intellectual property matter is being reviewed by a specialized team within the biotechnology division.
WEIDNER, ADAM M is the busiest examiner, with 1 pending office action. This is the only pending action for the portfolio, meaning that the success of the entire pending portfolio depends on this one interaction. For the practitioner, this means that prosecution strategy must be tailored to the specific technical requirements of this examiner. The existence of only a single pending office action indicates a very focused and lean prosecution pipeline for the company at this time.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| WEIDNER, ADAM M | 1 | 63.7% | +33.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18549388 | CLEARANCE ASSAY | WEIDNER, ADAM M | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18549388 | CLEARANCE ASSAY | WEIDNER, ADAM M | — |
| Art Unit | Apps |
|---|---|
| 1675 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18549388 | CLEARANCE ASSAY | WEIDNER, ADAM M | 1675 | §103§112 | Non-Final OA | — | Pending | Sep 07, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialAkershus Universitetssykehus HF has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Adam M Weidner has the most, with 1 of Akershus Universitetssykehus HF's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
